Drugs such as Ozempic, Rybelsus and Wegovy have made news for their abilities to treat diabetes and encourage weight loss. These drugs, called...

MONDAY, Aug. 12, 2024 -- For patients with type 2 diabetes, treatment with tirzepatide (a dual glucagon-like peptide 1 and glucose-dependent...

MONDAY, Aug. 12, 2024 -- Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with lower rates of hyperkalemia and a...

FRIDAY, Aug. 23, 2024 -- Research has already proven that the blockbuster weight-loss drug Wegovy (semaglutide) can slash a person's odds for heart...

American reality TV star, Kylie Jenner has denied taking Ozempic to lose weight after having her two kids. In a recent interview with British Vogue,...

Viking Therapeutics (VKTX) has developed a best-in-breed GLP-1 drug. The company is poised to gain a large portion of the massive weight loss drug...

NEW YORK, Aug. 19 (Xinhua) -- Ozempic and other GLP-1 drugs were supposed to revolutionize the battle against obesity, but evidence showed big...

Radio: The weight-loss expert is on Newstalk for a discussion of Ozempic and similar drugs. Prof Luke O’Neill, the guest host, needs to push back...

TUESDAY, Aug. 20, 2024 -- Tirzepatide, the blockbuster GLP-1 medicine known as Mounjaro for diabetes and Zepbound for weight loss, cut the odds that...

The majority of cancer patients involved in a landmark Perth clinical trial remain in remission years later after a breakthrough treatment that...